Typhoid Vaccine (Vi Polysaccharide and Conjugate)
Form: Injectable suspension (IM), Capsules (oral, live attenuated)
Strength: 0.5 mL
Reference Brands: Typhim Vi. Vivotif (US)
Category: Vaccines
Typhoid Vi polysaccharide and conjugate vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in accordance with GMP and IVDR standards. In the US, FDA approval involves rigorous clinical evaluation, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These vaccines undergo validation, stability testing, and comprehensive audits, with detailed documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective typhoid immunization solutions worldwide, vital for disease prevention and outbreak control.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Inactivated Vaccines
Strength: Dose and concentration depend on formulations
Form: Injectable suspension (IM administration), Lyophilized powder for reconstitution
Reference Brands: Sinovac Coronavac. Covaxin(EU)
View Details Get EnquiryViral Vector Vaccines
Strength: 0.5 mL
Form: Intramuscular injectable suspension (IM)
Reference Brands: US: Johnson & Johnson’s Janssen (Jcovden)
View Details Get EnquirymRNA-based Vaccines
Strength: 30 µg and 100 µg
Form: Injectable suspension
Reference Brands: Comirnaty, Spikevax(US)
View Details Get EnquiryMeningococcal Vaccine
Strength: 0.5 mL
Form: Vial or pre-filled syringe (injectable), Conjugate vaccines
Reference Brands: Menactra, Menveo(US)
View Details Get Enquiry